| Serial Number | 79417429 |
| Word Mark | QUOTIENT SCIENCES |
| Filing Date | Tuesday, September 17, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, December 1, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Contract packaging services in the nature of packaging and labelling of pharmaceutical and biopharmaceuticals for distribution on behalf of third parties; contract packaging and labelling for other in the nature of merchandise packaging and labelling for others; storage services, namely, warehousing and temperature controlled storage of goods for others; transportation logistics services, namely, arranging transportation of goods for others; packaging articles to the order and specification of others; contract packaging of pharmaceutical, biopharmaceutical and clinical supplies and materials for others |
| Goods and Services | Clinical research in the field of pharmacology and medical research; medical and scientific research, namely, conducting clinical trials for others; medical research, namely, conducting clinical trials for others in the field of pharmaceutical and biopharmaceutical products; pharmaceutical and biopharmaceutical research services; pharmaceutical and biopharmaceutical testing services; research relating to science namely, scientific research; Scientific research in the nature of basic and clinical research in the fields of pharmacology, pharmaceuticals and biopharmaceuticals; Evaluation and analysis of the efficacy and dosages of pharmaceutical and biopharmaceutical products of others and dosages in the nature of analysis and evaluation of pharmaceutical and biopharmaceutical products and dosages of others to determine conformity with certification standards and to assure compliance with industry standards; pharmaceutical and biopharmaceutical product evaluation; providing medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals and clinical trials; biological research; research and development of vaccines and medicines; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical products development; pharmaceutical and biopharmaceutical formulation design and development services, namely development of pharmaceutical and biopharmaceutical preparations and medicines; pre-formulation screening services, namely conducting early evaluations in the field of new pharmaceutical and testing, inspection and research of pharmaceuticals; scientific research in the nature of conducting clinical trials for others for the purpose of optimisation of pharmaceutical and biopharmaceutical formulations and dosage through clinical testing; development of pharmaceutical and biopharmaceutical preparations and medicines, research and development of vaccines and medicines, product research and development, product development for others; Research relating to medicine, namely, medical research in the field of pharmacology; Medical research in the nature of basic and clinical research in the field of pharmacology; consultancy relating to testing, inspection and research of pharmaceuticals and biopharmaceuticals; consultancy in the field of pharmacology; clinical pharmacology, namely technical research, testing and consulting in the field of pharmaceutical and biopharmaceutical studies; laboratory research services relating to pharmaceuticals. |
| Goods and Services | Custom manufacture of pharmaceuticals and biopharmaceuticals; custom manufacture of pharmaceuticals and biopharmaceuticals for clinical trial purposes; manufacturing services for clinical trials, namely manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; Providing information in the field of custom manufacturing and testing of pharmaceutical and biopharmaceutical products. |
| NOT AVAILABLE | SCIENCES |
| International Class | 039 - Transport; packaging and storage of goods; travel arrangement. |
| US Class Codes | 100, 105 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 13, 2025 |
| Primary Code | 039 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 13, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 13, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Quotient Sciences Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, February 20, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, March 13, 2025 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, March 14, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 14, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 17, 2025 | ASSIGNED TO EXAMINER |
| Monday, April 14, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, April 15, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, June 14, 2025 | REFUSAL PROCESSED BY MPU |
| Saturday, June 14, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, June 23, 2025 | ASSIGNED TO LIE |
| Saturday, July 5, 2025 | REFUSAL PROCESSED BY IB |
| Monday, December 1, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 1, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 1, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |